Once-weekly exenatide in type 2 diabetes

By Parmar Dinesh  

International Journal of Diabetes in Developing Countries, Vol. 31, Iss. 2, 2011-04 ,pp. : 121-122

Springer Publishing Company

Access to resources Recommend Favorite

A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study

By Nauck M.   Duran S.   Kim D.   Johns D.   Northrup J.   Festa A.   Brodows R.   Trautmann M.  

Diabetologia, Vol. 50, Iss. 2, 2007-02 ,pp. : 259-267

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and tolerability of acarbose in Asian patients with type 2 diabetes inadequately controlled with diet and sulfonylureas

By Lin B.J.   Wu H.-P.   Huang H.S.   Huarng J.   Sison A.   bin Abdul Kadir D.K.   Cho C.-G.   Sridama W.   The Writing Group for the Asian Study of Acarbose with Sulfonylureas  

Journal of Diabetes and its Complications, Vol. 17, Iss. 4, 2003-07 ,pp. : 179-185

Elsevier

Access to resources Recommend Favorite

Clinical overview of linagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with Type 2 diabetes mellitus

By Forst Thomas   Pfützner Andreas  

Expert Review of Endocrinology and Metabolism, Vol. 8, Iss. 1, 2013-01 ,pp. : 21-35

Informa Healthcare

Access to resources Recommend Favorite

Clinical risk factors and the role of VDR gene polymorphisms in diabetic retinopathy in Polish type 2 diabetes patients

By Cyganek K.   Mirkiewicz-Sieradzka B.   Malecki M.   Wolkow P.   Skupien J.   Bobrek J.   Czogala M.   Klupa T.   Sieradzki J.  

Acta Diabetologica, Vol. 43, Iss. 4, 2006-12 ,pp. : 114-119

Springer Publishing Company

Access to resources Recommend Favorite